| 注册
首页|期刊导航|实用医学杂志|升气壮阳方联合标准化屋尘螨疫苗免疫治疗儿童变应性哮喘的临床疗效及安全性评价

升气壮阳方联合标准化屋尘螨疫苗免疫治疗儿童变应性哮喘的临床疗效及安全性评价

郑燕霞 刘卓勋 李冰洁 江文文 许尤佳

实用医学杂志Issue(11):1855-1858,4.
实用医学杂志Issue(11):1855-1858,4.DOI:10.3969/j.issn.1006-5725.2015.11.044

升气壮阳方联合标准化屋尘螨疫苗免疫治疗儿童变应性哮喘的临床疗效及安全性评价

Sheng-qi-zhuang-yang formula combined with specific immunotherapy with standardized house dust mite vaccine on allergic asthmatic children:A preliminary effect and safety assessment

郑燕霞 1刘卓勋 1李冰洁 2江文文 1许尤佳1

作者信息

  • 1. 510120 广州市,广东省中医院
  • 2. 510406 广州市,中国南方航空股份有限公司航空卫生中心
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and safety of Sheng-qi-zhuang-yang formula combined with specific immunotherapy (SIT) with standardized house dust mite vaccine on allergic asthmatic children. Methods Participants were 100 children with mild to moderate allergic asthma , who were receiving SIT at Guangdong Provincial Hospital of Chinese Medicine from Jan 2011 to Dec 2013 , who were divided into treatment group and control group. Patients in the treatment group received Sheng-qi-zhuang-yang Decoction combined with SIT while patients in the control group received SIT alone. Asthma symptom scores, respiratory function and related adverse events were compared before and after treatment, between groups. Results The desensitization treatment functions was ahead of time than expected in both groups. There is no significant difference between groups in terms of respiratory function and adverse effects. Conclusion Sheng-qi-zhuang-yang decoction combined with SIT for allergic asthmatic children seems to advance clinical effect without increasing adverse events. Further large scale clinical trial is required to confirm this.

关键词

变应性哮喘/升气壮阳方/儿童/屋尘螨/免疫治疗

Key words

Allergic asthma/Sheng-qi-zhuang-yang decoction/formula/Children/House dust mite/Immunotherapy

引用本文复制引用

郑燕霞,刘卓勋,李冰洁,江文文,许尤佳..升气壮阳方联合标准化屋尘螨疫苗免疫治疗儿童变应性哮喘的临床疗效及安全性评价[J].实用医学杂志,2015,(11):1855-1858,4.

基金项目

广东省中医院中医药科学技术研究专项资助 ()

实用医学杂志

OA北大核心CSTPCD

1006-5725

访问量0
|
下载量0
段落导航相关论文